MENU
+Compare
SPHDF
Stock ticker: OTC
AS OF
May 28 closing price
Price
$14.75
Change
-$1.15 (-7.23%)
Capitalization
192.42M

SPHDF Santhera Pharmaceuticals Holdings Ltd. Forecast, Technical & Fundamental Analysis

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs... Show more

SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SPHDF with price predictions
Jun 27, 2025

SPHDF's Indicator enters downward trend

The Aroon Indicator for SPHDF entered a downward trend on June 27, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 171 similar instances where the Aroon Indicator formed such a pattern. In of the 171 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

SPHDF moved below its 50-day moving average on May 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPHDF crossed bearishly below the 50-day moving average on May 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Momentum Indicator moved above the 0 level on June 11, 2025. You may want to consider a long position or call options on SPHDF as a result. In of 28 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SPHDF just turned positive on June 17, 2025. Looking at past instances where SPHDF's MACD turned positive, the stock continued to rise in of 18 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPHDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.507) is normal, around the industry mean (16.366). P/E Ratio (2.519) is within average values for comparable stocks, (58.189). SPHDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (3.452) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPHDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Hohenrainstrasse 24
Phone
+41 619068950
Employees
51
Web
https://www.santhera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGGX42.300.21
+0.50%
MFS Core Equity R1
HEQCX5.450.02
+0.37%
Monteagle Opportunity Equity Instl
RLCAX8.710.03
+0.35%
Columbia Disciplined Value A
ALTFX151.930.49
+0.32%
AB Sustainable Global Thematic A
PGEKX22.170.06
+0.27%
Victory Pioneer Global Equity R6

SPHDF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with GYRE. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then GYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
GYRE - SPHDF
82%
Closely correlated
+0.54%
HRMY - SPHDF
37%
Loosely correlated
+0.38%
SPRC - SPHDF
34%
Loosely correlated
+0.72%
INM - SPHDF
33%
Poorly correlated
-2.31%
RVMD - SPHDF
33%
Poorly correlated
-1.52%
More